As of Sep 23
| +0.054 / +33.57%|
The 1 analysts offering 12-month price forecasts for Skystar Bio-Pharmaceutical Co have a median target of 2.50, with a high estimate of 2.50 and a low estimate of 2.50. The median estimate represents a +1,062.52% increase from the last price of 0.22.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.